James O'Shaughnessy, Director of Frontline plc (“Frontline” or the “Company”), has on September 8th, 2025, exercised 44,000 synthetic options in Frontline under its share option scheme approved by the Board of Directors of the Company on December 7, 2021.

Please see the attached form for notification and public disclosure of transaction attached. 

This notification has been publicly disclosed in accordance with Article 19 of the Market Abuse Regulation section 5-12 of the Norwegian Securities Trading Act.